BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 18653429)

  • 1. Pharmacist screening for depression among patients with diabetes in an urban primary care setting.
    Knight DE; Draeger RW; Heaton PC; Patel NC
    J Am Pharm Assoc (2003); 2008; 48(4):518-21. PubMed ID: 18653429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depressive symptoms in patients with type 2 diabetes in the ambulatory care setting: opportunities to improve outcomes in the course of routine care.
    Shah BM; Gupchup GV; Borrego ME; Raisch DW; Knapp KK
    J Am Pharm Assoc (2003); 2008; 48(6):737-43. PubMed ID: 19019802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist-led group medical appointments for the management of type 2 diabetes with comorbid depression in older adults.
    Taveira TH; Dooley AG; Cohen LB; Khatana SA; Wu WC
    Ann Pharmacother; 2011 Nov; 45(11):1346-55. PubMed ID: 22028418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comorbidity of anxiety and depression in general medical patients: a longitudinal study.
    Zung WW; Magruder-Habib K; Velez R; Alling W
    J Clin Psychiatry; 1990 Jun; 51 Suppl():77-80; discussion 81. PubMed ID: 2189878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the Zung Self-Rating Depression Scale in cancer patients: feasibility as a screening tool.
    Dugan W; McDonald MV; Passik SD; Rosenfeld BD; Theobald D; Edgerton S
    Psychooncology; 1998; 7(6):483-93. PubMed ID: 9885089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and humanistic impact of potential misdiagnosis of bipolar disorder among patients with major depressive disorder in a commercially insured population.
    Kamat SA; Rajagopalan K; Pethick N; Willey V; Bullano M; Hassan M
    J Manag Care Pharm; 2008 Sep; 14(7):631-42. PubMed ID: 18774873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist-initiated peripheral arterial disease screening program in a community pharmacy setting.
    Winfrey C; Wortman S; Frede S; Kunze N; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2011; 51(3):373-7. PubMed ID: 21555289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression and diabetes: Establishing the pharmacist's role in detecting comorbidity in pregnant women.
    Ragland D; Payakachat N; Hays EB; Banken J; Dajani NK; Ott RE
    J Am Pharm Assoc (2003); 2010 Mar-Apr 1; 50(2):195-9. PubMed ID: 20199962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
    Wilson C; Twigg G
    J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
    Rosser S; Frede S; Conrad WF; Heaton PC
    J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting and managing depression in type II diabetes: PHQ-9 is the answer!
    Acee AM
    Medsurg Nurs; 2010; 19(1):32-8. PubMed ID: 20336982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and rates of recognition of depressive disorders in internal medicine outpatient departments of 23 general hospitals in Shenyang, China.
    Qin X; Wang W; Jin Q; Ai L; Li Y; Dong G; Liu L; Phillips MR
    J Affect Disord; 2008 Sep; 110(1-2):46-54. PubMed ID: 18261805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between depressive symptoms and cardiovascular risk factors among selected Latino patients at a community clinic.
    Glassy CM; Lemus H; Cronan T; Glassy MS; Talavera GA
    Psychol Health Med; 2010 Mar; 15(2):117-26. PubMed ID: 20391229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic, clinical and psychosocial factors identify a high-risk group for depression screening among predominantly Hispanic patients with Type 2 diabetes in safety net care.
    Ell K; Katon W; Lee PJ; Guterman J; Wu S
    Gen Hosp Psychiatry; 2015; 37(5):414-9. PubMed ID: 26059979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized effectiveness trial of interpersonal psychotherapy for depressed adolescents.
    Mufson L; Dorta KP; Wickramaratne P; Nomura Y; Olfson M; Weissman MM
    Arch Gen Psychiatry; 2004 Jun; 61(6):577-84. PubMed ID: 15184237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for symptoms of depression by physical therapists managing low back pain.
    Haggman S; Maher CG; Refshauge KM
    Phys Ther; 2004 Dec; 84(12):1157-66. PubMed ID: 15563256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adequacy of depression management in the primary care setting.
    Joo JH; Solano FX; Mulsant BH; Reynolds CF; Lenze EJ
    Psychiatr Serv; 2005 Dec; 56(12):1524-8. PubMed ID: 16339613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety and depression symptoms in patients with diabetes.
    Collins MM; Corcoran P; Perry IJ
    Diabet Med; 2009 Feb; 26(2):153-61. PubMed ID: 19236618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of the 9-Item Patient Health Questionnaire for Depression Assessment in Primary Care Patients With Type 2 Diabetes.
    Willborn RJ; Barnacle M; Maack B; Petry N; Werremeyer A; Strand MA
    J Psychosoc Nurs Ment Health Serv; 2016 Jan; 54(1):56-63. PubMed ID: 26565416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of generalized anxiety disorder in Chinese primary care.
    Ying DG; Jiang S; Yang H; Zhu S
    Postgrad Med; 2010 Jul; 122(4):32-8. PubMed ID: 20675969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.